Evidence map›Paper›PMID 26136560›Full record

ArticleAmerican journal of physiology. Renal physiology2015

Calmodulin and CaMKII modulate ENaC activity by regulating the association of MARCKS and the cytoskeleton with the apical membrane.

Abdel A Alli, Hui-Fang Bao, Bing-Chen Liu, Ling Yu, Summer Aldrugh, Darrice S Montgomery, He-Ping Ma, Douglas C Eaton

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Review
  3. SECS, drugs, and Rac1&Rho: regulation of EnNaC in vascular endothelial cells.Pflugers Archiv : European journal of physiology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. PIPBiology · 2022
    Article
  12. Nutrients · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Abdel A AlliCenter for Cell and Molecular Signaling, Department of Physiology, Emory University School of Medicine; Atlanta, Georgia aalli@emory.edu.
Hui-Fang BaoCenter for Cell and Molecular Signaling, Department of Physiology, Emory University School of Medicine; Atlanta, Georgia.
Bing-Chen LiuCenter for Cell and Molecular Signaling, Department of Physiology, Emory University School of Medicine; Atlanta, Georgia.
Ling YuCenter for Cell and Molecular Signaling, Department of Physiology, Emory University School of Medicine; Atlanta, Georgia.
Summer AldrughCenter for Cell and Molecular Signaling, Department of Physiology, Emory University School of Medicine; Atlanta, Georgia.
Darrice S MontgomeryCenter for Cell and Molecular Signaling, Department of Physiology, Emory University School of Medicine; Atlanta, Georgia.
He-Ping MaCenter for Cell and Molecular Signaling, Department of Physiology, Emory University School of Medicine; Atlanta, Georgia.
Douglas C EatonCenter for Cell and Molecular Signaling, Department of Physiology, Emory University School of Medicine; Atlanta, Georgia.
Emory University · US

Funding

REGULATION OF SODIUM IN TIGHT EPITHELIAR37DK037963 · NIDDK · EMORY UNIVERSITY · PI EATON, DOUGLAS C. · 2002 to 2011
$3.8M
Regulation of ENaC by Anionic PhospholipidsR01DK067110 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MA, HE-PING · 2004 to 2012
$1.6M
Role of Ion Channels in Kidney DiseasesR01DK100582 · NIDDK · EMORY UNIVERSITY · PI MA, HE-PING · 2014 to 2017
$1.4M
Calicum, MARCKS, and PIP2 regulation of ENaCK01DK099617 · NIDDK · UNIVERSITY OF FLORIDA · PI ALLI, ABDEL AYUBE · 2014 to 2018
$685k
REGULATION OF SODIUM TRANSPORT IN TIGHT EPITHELIAR01DK037963 · NIDDK · EMORY UNIVERSITY · PI EATON, DOUGLAS C · 1987 to 2001
$496k
NIDDK NIH HHS 1K01 1DK099617NIDDK NIH HHS 5R01 DK067110NIDDK NIH HHS K01 DK099617NIDDK NIH HHS R01 DK100582
6 · The paper itself

Abstract

Phosphatidylinositol bisphosphate (PIP2) regulates epithelial sodium channel (ENaC) open probability. In turn, myristoylated alanine-rich C kinase substrate (MARCKS) protein or MARCKS-like protein 1 (MLP-1) at the plasma membrane regulates the delivery of PIP2 to ENaC. MARCKS and MLP-1 are regulated by changes in cytosolic calcium; increasing calcium promotes dissociation of MARCKS from the membrane, but the calcium-regulatory mechanisms are unclear. However, it is known that increased intracellular calcium can activate calmodulin and we show that inhibition of calmodulin with calmidazolium increases ENaC activity presumably by regulating MARCKS and MLP-1. Activated calmodulin can regulate MARCKS and MLP-1 in two ways. Calmodulin can bind to the effector domain of MARCKS or MLP-1, inactivating both proteins by causing their dissociation from the membrane. Mutations in MARCKS that prevent calmodulin association prevent dissociation of MARCKS from the membrane. Calmodulin also activates CaM kinase II (CaMKII). An inhibitor of CaMKII (KN93) increases ENaC activity, MARCKS association with ENaC, and promotes MARCKS movement to a membrane fraction. CaMKII phosphorylates filamin. Filamin is an essential component of the cytoskeleton and promotes association of ENaC, MARCKS, and MLP-1. Disruption of the cytoskeleton with cytochalasin E reduces ENaC activity. CaMKII phosphorylation of filamin disrupts the cytoskeleton and the association of MARCKS, MLP-1, and ENaC, thereby reducing ENaC open probability. Taken together, these findings suggest calmodulin and CaMKII modulate ENaC activity by destabilizing the association between the actin cytoskeleton, ENaC, and MARCKS, or MLP-1 at the apical membrane.

Indexed as

AnimalsCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2CalmodulinCell LineCell MembraneCytoskeletonEnzyme InhibitorsEpithelial CellsEpithelial Sodium ChannelsFilaminsImidazolesIntracellular Signaling Peptides and ProteinsMembrane ProteinsMyristoylated Alanine-Rich C Kinase SubstrateNephronsCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2calmidazoliumCalmodulinEnzyme InhibitorsEpithelial Sodium ChannelsFilaminsImidazolesIntracellular Signaling Peptides and ProteinsMembrane ProteinsMyristoylated Alanine-Rich C Kinase SubstratecalciumCaMKIIENaCfilaminMARCKS

Identifiers

PMID26136560
PMCPMC4556887
OpenAlexW2184964708

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.